Sign in

CIK 0000315545

  • Non-accelerated filer
  • Smaller reporting company

PROVECTUS BIOPHARMACEUTICALS, INC.

Sign in to watch
Ticker
PVCT
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
900031917
Phone
+1 866-594-5999
Business address
800 S. GAY STREET, SUITE 1610, KNOXVILLE, TN, 37929
Former names
PROVECTUS PHARMACEUTICALS INC, PROVECTUS PHARMACEUTICAL INC, ZAMAGE DIGITAL IMAGING INC, SPM GROUP INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 53 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-06-20 Horowitz Bruce COO Exercise or conversion · 8% Secured Convertible Promissory Notes due 2021 −0 0
2021-06-20 Horowitz Bruce COO Exercise or conversion · Series D-1 Convertible Preferred Stock +38,473 38,473
2021-06-17 Horowitz Bruce COO Grant or award · 8% Secured Convertible Promissory Notes due 2021 +0
2020-11-10 Horowitz Bruce Chief Operating Officer Grant or award +800,000 2,227,243
2020-11-10 Horowitz Bruce Chief Operating Officer Grant or award · Stock Options (Right to Buy) +2,425,000 2,425,000

Page 1 of 1 · 5 trades